Cardiac Catheterization Denied by Insurance? How to Build a Successful Appeal

Cardiac catheterization — or coronary angiography — is the gold standard for diagnosing coronary artery disease, evaluating valve function, and guiding decisions about coronary intervention. When it is recommended by a cardiologist, a denial from an insurance company can feel both dangerous and absurd. But denials do happen, and they are usually reversible with the right documentation.

Why Cardiac Catheterization Claims Get Denied

Non-invasive testing not performed first. The most common denial reason is that the insurer requires non-invasive cardiac testing before approving invasive catheterization. This typically means a stress test — exercise treadmill test (ETT), nuclear stress test (myocardial perfusion imaging), or stress echocardiogram — to document ischemia or reduced ejection fraction. If you went directly to catheterization based on symptoms and physician judgment, without a documented stress test, the insurer may deny the claim.

Stress test results not meeting threshold. Even when a stress test is performed, the insurer may deny catheterization if the results don't clearly meet their threshold for "high-risk" findings. Specific findings that typically meet criteria include:

• Significant ST-segment depression (≥1.5–2mm) at low workload
• Exercise-induced hypotension
• Severely abnormal nuclear perfusion scan (large perfusion defect, wall motion abnormality)
• Ejection fraction <35% on stress echocardiogram
• Duke Treadmill Score in the high-risk range

Borderline or "intermediate" stress test results may prompt a denial, with the insurer arguing that additional non-invasive testing should be performed first.

Troponin levels and acute presentation not documented. For patients presenting with suspected acute coronary syndrome (ACS) — unstable angina, NSTEMI, or STEMI — urgent catheterization is standard of care. If your troponin elevation or ECG findings aren't clearly documented, the insurer may not recognize the urgency of the indication.

Stable chest pain management argument. For patients with stable coronary artery disease and stable angina, the COURAGE and ISCHEMIA trials showed that optimal medical therapy (OMT) is equivalent to PCI for many endpoints in stable patients. Insurers may cite these trials to argue that catheterization (and possible stenting) should only follow a trial of maximal medical management.

Repeated catheterization without clear new indication. If you've had a previous catheterization, the insurer may require documentation of new symptoms, interval changes, or a new clinical event before approving repeat catheterization.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization issues. Elective catheterization almost always requires prior authorization. Emergency catheterization for ACS should not require pre-authorization, but retroactive denials can still occur.

What Clinical Guidelines Support

The American College of Cardiology (ACC) and American Heart Association (AHA) publish detailed appropriate use criteria for coronary angiography. These criteria classify specific clinical scenarios as "appropriate," "maybe appropriate," or "rarely appropriate." Citing the applicable AUC category for your clinical scenario in the appeal letter is one of the most effective strategies.

For patients with high-risk stress test findings, significant symptoms, or acute presentations, coronary angiography is consistently classified as appropriate under ACC/AHA criteria.

Building Your Appeal

Include all stress test reports and imaging. Provide the full stress test report, including ECG tracings if applicable, nuclear imaging with quantitative perfusion data, or echocardiography measurements. The report should document the level of ischemia or functional abnormality.

Document symptom history in detail. The frequency, duration, and triggers of chest pain or anginal equivalents (dyspnea on exertion, jaw pain, left arm pain) should be documented in your cardiologist's notes. Canadian Cardiovascular Society (CCS) angina classification is a useful framework.

Provide ECG and biomarker data for acute presentations. For ACS presentations, include ECG tracings showing ischemic changes and serial troponin values with timestamps. This establishes urgency and clinical appropriateness.

Request a supporting letter from your cardiologist. The cardiologist should cite the specific ACC/AHA appropriate use criteria applicable to your case, explain why catheterization was indicated, and address any alternative management options that were considered and rejected.

Challenge "stable disease" arguments. If the insurer is citing ISCHEMIA trial data, have your cardiologist explain why your specific case requires catheterization: high-risk stress test findings, ongoing symptoms despite medical therapy, or new clinical events.

After an Internal Denial

Request external independent review by a board-certified cardiologist. External reviewers applying standard of care criteria are far more likely to uphold catheterization than the insurer's internal utilization reviewer.

Fight Back With ClaimBack

Cardiac catheterization is often lifesaving — and your cardiologist recommended it for a reason. ClaimBack helps you build the clinical case your insurer needs to see.

Start your appeal at ClaimBack

Related Reading

• What Is Medical Necessity?
• How to Write an Insurance Appeal Letter
• Internal vs. External Insurance Appeal: What's the Difference?